常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.29/--
|
|
企业价值
1.85B
|
| 资产负债 |
|
每股账面净值
0.91
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
25.10M
|
|
每股收益
8.66
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2025/11/07 20:26 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing. |

9.7 
